Canary has refiled an S-1 for a staked Injective ETF, with details on custodians, staking plan, and Cboe BZX listing. The ETF will track spot INJ and generate additional yield through staking. INJ price and derivatives markets show mixed signals, with modest recovery in spot price and easing futures open interest.

Leave a Reply